Background Secondary prevention is critical for patients with established atherosclerotic cardiovascular diseases (ASCVD).
Discover how proteomics data analysis and bioinformatics tools enhance mass spectrometry workflows for robust findings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results